"I have given the permission to launch the testing procedure. It will start now,” Health Minister Zahid Maleque said on Sunday, announcing the development.
The procedure will be used to determine if a person has the antibodies created in them to fight the virus.
An antibody test looks for antibodies that are made by the immune system in response to a threat, such as a specific virus. Antibodies can help fight infections. Antibodies can take several days or weeks to develop after people have an infection and may stay in their blood for several weeks or more after recovery.
There is a caveat. For the coronavirus disease, researchers still do not know if the presence of antibodies means that they are immune to COVID-19 in the future.
A rapid antibody testing kit can be used for sero-surveillance, convulsant plasma therapy and research.
According to the policy designed by Bangladesh, a rapid test kit must have these words written on its package: ‘this is not a diagnostic kit; the kit will be used only for detecting antibody, not in the acute stage’.
The combined sensitivity immunoglobulin M, which is developed at the beginning of the infection and immunoglobulin G, which is developed later, should be 90 percent in the kit and specificity should be 95 percent, according to the policy.
The sensitivity mentioned here describes the percentage of antibodies found in the blood after 14 days of COVID-19 symptoms subside.
Case started over ’unnatural’ death of writer Mushtaq in jail
Home minister says Mushtaq’s death will be investigated, if needed
PM Hasina set to speak on Bangladesh’s graduation from LDC status
Bangladesh logs 470 new virus cases, deaths rise by 11
Protests erupt at Shahbagh over writer Mushtaq’s death in jail
Four dead after bus rams autorickshaw in Bogura
